Company Report
Last edited a month ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#9
Performance (72m)
5.7% pa
Followed by
50
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#3rd Q Appendix 4C Cash Flow Re
Added a month ago

on life support 32 compressions & 2 breathes

Retired: CEO Richard Lipcombs & Neville Gardiner

Appointed: CEO David Morris, CFO Tim Luscombe,

reduced management by 25%

asx/piq/announcements/proteomics-strategic-

35355b455a3e0378686f1e8c045ea69a3908a8.png

510e33640a0f4884899117a696003e92e89132.png

3570c0795be538574b972c765346e2875a3da3.png

63668f071bcd507e4edd5df3f625b9121d8d14.png


4C has 2.2 months of cash .. could be a cap raising coming soon

A good story!!

d93d9abacbe271d657874abc07fefede54268a.png

5b6ae767a75cbc6afb9f7f96359ca5ffbf96d7.png


#Trades higher
Added 5 months ago

No news, micro cap trades higher today.

https://www.proteomics.com.au/

Proteomics International Laboratories Ltd (PIQ) is a medical technology company at the forefront of precision diagnostics and bio-analytical services. The Company specialises in the area of proteomics - the industrial scale study of the structure and function of proteins. Proteomics International's mission is to improve the quality of lives by the creation and application of tools that enable the improved treatment of disease.

No fundamentals here. Just sheer speculative conviction..

3f6ae90431e5425dd2499438abc651b67084b5.jpeg